Jenny Barnett
Chief Executive Officer at Monument Therapeutics Ltd.
Profile
Jenny Barnett is currently the Chief Executive Officer at Monument Therapeutics Ltd.
Prior to this, she worked as the Senior Scientific Director at Cambridge Cognition Ltd.
and as the Chief Scientific Officer at Cambridge Cognition Holdings Plc.
Jenny Barnett active positions
| Companies | Position | Start |
|---|---|---|
Monument Therapeutics Ltd.
 Monument Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Monument Therapeutics Ltd. is a British UK-based biotechnology company that focuses on bringing precision medicine to neuroscience drug development. The company is based in Bottisham, UK, and was founded in 2019. The company was formed as a spin-out from Cognition and has a mission to use precision medicine to develop therapeutic products for patients with substantial central nervous system indications and significant unmet medical needs. Monument Tx has a well-balanced pipeline that includes two lead programs, and proprietary biomarkers developed by the team allow for precise selection of patients most likely to benefit from treatment. The therapeutic products under development are novel formulations utilizing well-characterized technology. Jenny Barnett has been the CEO of the company since 2019. | Chief Executive Officer | 31/12/2018 |
Former positions of Jenny Barnett
| Companies | Position | End |
|---|---|---|
| CAMBRIDGE COGNITION HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 31/03/2022 |
Cambridge Cognition Ltd.
 Cambridge Cognition Ltd. Packaged SoftwareTechnology Services Cambridge Cognition Ltd. operates as a neuroscience technology company delivering near-patient assessment solutions to improve the understanding, diagnosis and treatment of neurological and psychiatric disorders. It offers CANTAB Tests and Services, CANTAB mobile and CANTABeclipse. The company was founded in 2002 and is headquartered in Cambridge, GB. | Chief Tech/Sci/R&D Officer | 02/05/2013 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CAMBRIDGE COGNITION HOLDINGS PLC | Technology Services |
| Private companies | 2 |
|---|---|
Cambridge Cognition Ltd.
Cambridge Cognition Ltd. Packaged SoftwareTechnology Services Cambridge Cognition Ltd. operates as a neuroscience technology company delivering near-patient assessment solutions to improve the understanding, diagnosis and treatment of neurological and psychiatric disorders. It offers CANTAB Tests and Services, CANTAB mobile and CANTABeclipse. The company was founded in 2002 and is headquartered in Cambridge, GB. | Technology Services |
Monument Therapeutics Ltd.
Monument Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Monument Therapeutics Ltd. is a British UK-based biotechnology company that focuses on bringing precision medicine to neuroscience drug development. The company is based in Bottisham, UK, and was founded in 2019. The company was formed as a spin-out from Cognition and has a mission to use precision medicine to develop therapeutic products for patients with substantial central nervous system indications and significant unmet medical needs. Monument Tx has a well-balanced pipeline that includes two lead programs, and proprietary biomarkers developed by the team allow for precise selection of patients most likely to benefit from treatment. The therapeutic products under development are novel formulations utilizing well-characterized technology. Jenny Barnett has been the CEO of the company since 2019. | Health Technology |
- Stock Market
- Insiders
- Jenny Barnett